{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:20:53Z","timestamp":1788967253041,"version":"build-2803163510"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,5,30]],"date-time":"2015-05-30T00:00:00Z","timestamp":1432944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s40266-015-0268-7","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T11:08:30Z","timestamp":1432897710000},"page":"419-426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Pain in the Frail or Elderly Patient: Does Tapentadol Have a Role?"],"prefix":"10.1007","volume":"32","author":[{"given":"Felicity C.","family":"Veal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,30]]},"reference":[{"key":"268_CR1","volume-title":"Classification of chronic pain","author":"H Merskey","year":"1994","unstructured":"Merskey H, Bogduk N. Classification of chronic pain. 2nd ed. Seattle: IASP Press; 1994.","edition":"2"},{"key":"268_CR2","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/pme.12162","volume":"14","author":"P Siddall","year":"2013","unstructured":"Siddall P. Is chronic pain a disease? Pain Med. 2013;14:1289\u201390.","journal-title":"Pain Med."},{"key":"268_CR3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11916-010-0148-0","volume":"14","author":"E Chai","year":"2010","unstructured":"Chai E, Horton JR. Managing pain in the elderly population: pearls and pitfalls. Curr Pain Headache Rep. 2010;14:409\u201317.","journal-title":"Curr Pain Headache Rep"},{"key":"268_CR4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jamda.2013.04.009","volume":"14","author":"A Lukas","year":"2013","unstructured":"Lukas A, Mayer B, Fialova D, Topinkova E, Gindin J, Onder G, et al. Treatment of pain in European nursing homes: results from the Services and Health for Elderly in Long TERm Care (SHELTER) study. J Am Med Dir Assoc. 2013;14:821\u201331.","journal-title":"J Am Med Dir Assoc"},{"key":"268_CR5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jamda.2012.12.010","volume":"14","author":"A Lukas","year":"2013","unstructured":"Lukas A, Mayer B, Fialova D, Topinkova E, Gindin J, Onder G, et al. Pain characteristics and pain control in European nursing homes: cross-sectional and longitudinal results from the Services and Health for Elderly in Long TERm care (SHELTER) study. J Am Med Dir Assoc. 2013;14:421\u20138.","journal-title":"J Am Med Dir Assoc"},{"key":"268_CR6","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.clinthera.2013.09.008","volume":"35","author":"TJ Atkinson","year":"2013","unstructured":"Atkinson TJ, Fudin J, Pandula A, Mirza M. Medication pain management in the elderly: unique and underutilized analgesic treatment options. Clin Ther. 2013;35:1669\u201389.","journal-title":"Clin Ther"},{"key":"268_CR7","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1532-5415.2009.02376.x","volume":"57","author":"American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons","year":"2009","unstructured":"American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological Management of Persistent Pain in Older Persons. J Am Geriatr Soc. 2009;57:1331\u201346.","journal-title":"J Am Geriatr Soc"},{"key":"268_CR8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2165\/00002018-200932060-00003","volume":"32","author":"JB Barber","year":"2009","unstructured":"Barber JB, Gibson SJ. Treatment of chronic non-malignant pain in the elderly: safety considerations. Drug Saf. 2009;32:457\u201374.","journal-title":"Drug Saf"},{"key":"268_CR9","doi-asserted-by":"crossref","first-page":"s26","DOI":"10.4065\/mcp.2009.0646","volume":"85","author":"KE Schmader","year":"2010","unstructured":"Schmader KE, Baron R, Haanp\u00e4\u00e4 ML, Mayer J, O\u2019Connor AB, Rice AS, et al. Treatment considerations for elderly and frail patients with neuropathic pain. Mayo Clin Proc. 2010;85:s26\u201332.","journal-title":"Mayo Clin Proc"},{"issue":"3 Suppl 1","key":"268_CR10","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2012.11.011","volume":"126","author":"OA Leon-Casasola de","year":"2013","unstructured":"de Leon-Casasola OA. Opioids for chronic pain: new evidence, new strategies, safe prescribing. Am J Med. 2013;126(3 Suppl 1):S3\u201311.","journal-title":"Am J Med"},{"key":"268_CR11","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146\u201356.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"268_CR12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/gerona\/59.3.M255","volume":"59","author":"LP Fried","year":"2004","unstructured":"Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59:255\u201363.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"268_CR13","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/gerona\/glt162","volume":"69","author":"DJ Lowsky","year":"2014","unstructured":"Lowsky DJ, Olshansky SJ, Bhattacharya J, Goldman DP. Heterogeneity in healthy aging. J Gerontol A Biol Sci Med Sci. 2014;69:640\u20139.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"Suppl","key":"268_CR14","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpainsymman.2009.05.002","volume":"38","author":"PG Fine","year":"2009","unstructured":"Fine PG. Chronic pain management in older adults: special considerations. J Pain Symptom Manag. 2009;38(Suppl):S4\u201314.","journal-title":"J Pain Symptom Manag"},{"key":"268_CR15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/11599210-000000000-00000","volume":"29","author":"E Prommer","year":"2012","unstructured":"Prommer E, Ficek B. Management of pain in the elderly at the end of life. Drugs Aging. 2012;29:285\u2013305.","journal-title":"Drugs Aging"},{"key":"268_CR16","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2165\/00002512-200522080-00002","volume":"22","author":"K Auret","year":"2005","unstructured":"Auret K, Schug SA. Underutilisation of opioids in elderly patients with chronic pain: approaches to correcting the problem. Drugs Aging. 2005;22:641\u201354.","journal-title":"Drugs Aging"},{"key":"268_CR17","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1001\/archinte.161.22.2721","volume":"161","author":"F Landi","year":"2001","unstructured":"Landi F, Onder G, Cesari M, Gambassi G, Steel K, Russo A, et al. Pain management in frail, community-living elderly patients. Arch Intern Med. 2001;161:2721\u20134.","journal-title":"Arch Intern Med"},{"key":"268_CR18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/ageing\/afu072","volume":"43","author":"FC Veal","year":"2014","unstructured":"Veal FC, Bereznicki LR, Thompson AJ, Peterson GM. Pharmacological management of pain in Australian aged care facilities. Age Ageing. 2014;43:851\u20136.","journal-title":"Age Ageing"},{"issue":"Suppl 1","key":"268_CR19","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/ageing\/afs200","volume":"42","author":"A Abdulla","year":"2013","unstructured":"Abdulla A, Adams N, Bone M, Elliott AM, Gaffin J, Jones D, et al. Guidance on the management of pain in older people. Age Ageing. 2013;42(Suppl 1):i1\u201357.","journal-title":"Age Ageing"},{"key":"268_CR20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1533-2500.2008.00204.x","volume":"8","author":"J Pergolizzi","year":"2008","unstructured":"Pergolizzi J, Boger RH, Budd K, Dahan A, Erdine S, Hans G, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 2008;8:287\u2013313.","journal-title":"Pain Pract"},{"key":"268_CR21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF03262278","volume":"29","author":"AL Ojik van","year":"2012","unstructured":"van Ojik AL, Jansen PA, Brouwers JR, van Roon EN. Treatment of chronic pain in older people: evidence-based choice of strong-acting opioids. Drugs Aging. 2012;29:615\u201325.","journal-title":"Drugs Aging"},{"key":"268_CR22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00228-012-1387-2","volume":"69","author":"RE Hubbard","year":"2013","unstructured":"Hubbard RE, O\u2019Mahony MS, Woodhouse KW. Medication prescribing in frail older people. Eur J Clin Pharmacol. 2013;69:319\u201326.","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"268_CR23","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1503\/cmaj.051528","volume":"174","author":"AD Furlan","year":"2006","unstructured":"Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006;174(11):1589\u201394.","journal-title":"CMAJ"},{"key":"268_CR24","first-page":"179","volume":"10","author":"AD Kaye","year":"2010","unstructured":"Kaye AD, Baluch A, Scott JT. Pain management in the elderly population: a review. Ochsner J. 2010;10:179\u201387.","journal-title":"Ochsner J"},{"issue":"s2","key":"268_CR25","doi-asserted-by":"crossref","first-page":"s57","DOI":"10.1111\/j.1526-4637.2011.01307.x","volume":"13","author":"PG Fine","year":"2012","unstructured":"Fine PG. Treatment guidelines for the pharmacological management of pain in older persons. Pain Med. 2012;13(s2):s57\u201366.","journal-title":"Pain Med"},{"key":"268_CR26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/CIA.S30165","volume":"8","author":"R Rastogi","year":"2013","unstructured":"Rastogi R, Meek BD. Management of chronic pain in elderly, frail patients: finding a suitable, personalized method of control. Clin Interv Aging. 2013;8:37\u201346.","journal-title":"Clin Interv Aging"},{"key":"268_CR27","unstructured":"The Australian Pain Society. Pain in residential aged care facilities: management strategies. Sydney: 2005. https:\/\/www.apsoc.org.au\/PDF\/Publications\/Pain_in_Residential_Aged_Care_Facilities_Management_Strategies.pdf . Accessed 22 Feb 2015."},{"key":"268_CR28","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1001\/archinternmed.2010.450","volume":"170","author":"DH Solomon","year":"2010","unstructured":"Solomon DH, Rassen JA, Glynn RJ, Garneau K, Levin R, Lee J, et al. The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med. 2010;170:1979\u201386.","journal-title":"Arch Intern Med"},{"key":"268_CR29","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1001\/archinternmed.2010.391","volume":"170","author":"DH Solomon","year":"2010","unstructured":"Solomon DH, Rassen JA, Glynn RJ, Lee J, Levin R, Schneeweiss S. The comparative safety of analgesics in older adults with arthritis. Arch Intern Med. 2010;170:1968\u201376.","journal-title":"Arch Intern Med"},{"key":"268_CR30","unstructured":"National Institute for Clinical Excellence. Osteoarthritis: Care and management in adults. 2014. http:\/\/www.nice.org.uk\/guidance\/cg177 . Accessed 22 Feb 2015."},{"key":"268_CR31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cger.2007.12.008","volume":"24","author":"G McCleane","year":"2008","unstructured":"McCleane G. Pain perception in the elderly patient. Clin Geriatr Med. 2008;24:203\u201311.","journal-title":"Clin Geriatr Med"},{"key":"268_CR32","doi-asserted-by":"crossref","first-page":"c6764","DOI":"10.1136\/bmj.c6764","volume":"341","author":"LC Claridge","year":"2010","unstructured":"Claridge LC, Eksteen B, Smith A, Shah T, Holt AP. Acute liver failure after administration of paracetamol at the maximum recommended daily dose in adults. BMJ. 2010;341:c6764.","journal-title":"BMJ"},{"key":"268_CR33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00204-014-1432-2","volume":"89","author":"EM Lancaster","year":"2015","unstructured":"Lancaster EM, Hiatt JR, Zarrinpar A. Acetaminophen hepatotoxicity: an updated review. Arch Tox. 2015;89:193\u20139.","journal-title":"Arch Tox"},{"key":"268_CR34","doi-asserted-by":"crossref","unstructured":"Mitchell SJ, Kane AE, Hilmer SN. Age-related changes in the hepatic pharmacology and toxicology of paracetamol. Curr Gerontol Geriatr Res. 2011. doi: 10.1155\/2011\/624156 .","DOI":"10.1155\/2011\/624156"},{"key":"268_CR35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2710.2010.01193.x","volume":"36","author":"SJ Mitchell","year":"2011","unstructured":"Mitchell SJ, Hilmer SN, Murion BP, Matthews S. Hepatoxicity of therapeutic short-course paracetamol in hospital inpatients: impact of ageing and frailty. J Clin Pharm Ther. 2011;36:327\u201335.","journal-title":"J Clin Pharm Ther"},{"key":"268_CR36","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1001\/archinternmed.2010.442","volume":"170","author":"J Graf","year":"2010","unstructured":"Graf J. Analgesic use in the elderly: the \u201cpain\u201d and simple truth. Arch Intern Med. 2010;170:1976\u20138.","journal-title":"Arch Intern Med"},{"key":"268_CR37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2125.2010.03847.x","volume":"71","author":"AJ McLachlan","year":"2011","unstructured":"McLachlan AJ, Bath S, Naganathan V, Hilmer SN, Le Couteur DG, Gibson SJ, et al. Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment. Br J Clin Pharmacol. 2011;71:351\u201364.","journal-title":"Br J Clin Pharmacol"},{"key":"268_CR38","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/M14-2559","volume":"162","author":"R Chou","year":"2015","unstructured":"Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health pathways to prevention workshop. Ann Intern Med. 2015;162:276\u201386.","journal-title":"Ann Intern Med"},{"key":"268_CR39","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.clinthera.2013.09.026","volume":"35","author":"B Tracy","year":"2013","unstructured":"Tracy B, Morrison RS. Pain management in older adults. Clin Ther. 2013;35:1659\u201368.","journal-title":"Clin Ther"},{"key":"268_CR40","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4140\/TCP.n.2004.118","volume":"19","author":"SJ Ackerman","year":"2004","unstructured":"Ackerman SJ, Knight T, Schein J, Carter C, Staats P. Risk of constipation in patients prescribed fentanyl transdermal system or oxycodone hydrochloride controlled-release in a California Medicaid population. Consult Pharm. 2004;19:118\u201332.","journal-title":"Consult Pharm"},{"key":"268_CR41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/J354v19n04_05","volume":"19","author":"RA Lugo","year":"2005","unstructured":"Lugo RA, Satterfield KL, Kern SE. Pharmacokinetics of methadone. J Pain Palliative Care Pharm. 2005;19:13\u201324.","journal-title":"J Pain Palliative Care Pharm"},{"key":"268_CR42","doi-asserted-by":"crossref","unstructured":"Ray WA, Chung CP, Murray KT, Cooper WO, Hall K, Stein CM. Out-of-hospital mortality among patients receiving methadone for noncancer pain. JAMA Intern Med. 2015. doi: 10.1001\/jamainternmed.2014.6294 .","DOI":"10.1001\/jamainternmed.2014.6294"},{"key":"268_CR43","unstructured":"Janssen Ortho. Ultram\u00ae (tramadol hydrochloride) tablets: full prescription information. 2008. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/020281s032s033lbl.pdf . Accessed 18 April 2015."},{"key":"268_CR44","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/archinte.163.20.2433","volume":"163","author":"MJ Bair","year":"2003","unstructured":"Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbiditiy: a literature review. Arch Intern Med. 2003;163:2433\u201345.","journal-title":"Arch Intern Med"},{"key":"268_CR45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/2049463712438299","volume":"6","author":"O Seyfried","year":"2012","unstructured":"Seyfried O, Hester J. Opioids and endocrine dysfunction. Br J Pain. 2012;6:17\u201324.","journal-title":"Br J Pain"},{"key":"268_CR46","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1001\/jama.2009.1738","volume":"302","author":"SG Leveille","year":"2010","unstructured":"Leveille SG, Jones RN, Kiely DK, Hausdorff JM, Shmerling RH, Guralnik JM, et al. Chronic musculoskeletal pain and the occurrence of falls in an older population. JAMA. 2010;302:2214\u201321.","journal-title":"JAMA"},{"key":"268_CR47","unstructured":"National Institute for Clinical Excellence. Neuropathic pain: pharmacological management: the pharmacological management of neuropathic pain in adults in non-specialists settings. London: NICE; 2013. https:\/\/www.nice.org.uk\/guidance\/cg173 . Accessed 22 Feb 2015."},{"key":"268_CR48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12325-013-0002-y","volume":"30","author":"R Taylor","year":"2013","unstructured":"Taylor R, Pergolizzi JV, Raffa RB. Tapentadol extended release for chronic pain patients. Adv Ther. 2013;30:14\u201327.","journal-title":"Adv Ther"},{"key":"268_CR49","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ajg.2011.30","volume":"106","author":"M Camilleri","year":"2011","unstructured":"Camilleri M. Opioid-induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol. 2011;106:835\u201342.","journal-title":"Am J Gastroenterol"},{"key":"268_CR50","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1517\/14656566.2012.696097","volume":"13","author":"RB Raffa","year":"2012","unstructured":"Raffa RB, Buschmann H, Christoph T, Eichenbaum G, Englberger W, Flores CM, et al. Mechanistic and functional differentiation of tapentadol and tramadol. Expert Opin Pharmacother. 2012;13:1437\u201349.","journal-title":"Expert Opin Pharmacother"},{"key":"268_CR51","unstructured":"Scottish Medicines Consortium. Resubmission: tapentadol, 50, 100, 150, 200 and 250\u00a0mg prolonged-release tablets (palexia\u00ae SR). Glasgow: SIGN; 2011. http:\/\/www.scottishmedicines.org.uk\/files\/advice\/tapentadol_Palexia_SR_RESUBMISISON_FINAL_MAY_2011_for_website.pdf . Accessed 22 Feb 2015."},{"key":"268_CR52","unstructured":"Janssen Pharmaceuticals INC. Highlights of prescribing information\u2014Nucynta ER. 2012. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/200533s001lbl.pdf . Accessed 22 Feb 2015."},{"key":"268_CR53","unstructured":"Pharmaceutical Benefits Advisory Committee. Tapentadol, tablet, 50\u00a0mg, 100\u00a0mg, 150\u00a0mg, 200\u00a0mg and 250\u00a0mg (as hydrochloride) (sustained release), Palexia SR\u00ae public summary document. Department of Health, editor. Canberra: Australian Government; 2013. http:\/\/www.pbs.gov.au\/info\/industry\/listing\/elements\/pbac-meetings\/psd\/2013-11\/tapentadol . Accessed 22 Feb 2015."},{"key":"268_CR54","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2165\/11533440-000000000-00000","volume":"30","author":"M Afilalo","year":"2010","unstructured":"Afilalo M, Etropolski MS, Kuperwasser B, Kelly K, Okamoto A, Van Hove I, et al. Efficacy and safety of tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III study. Clin Drug Investig. 2010;30:489\u2013505.","journal-title":"Clin Drug Investig"},{"key":"268_CR55","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1517\/14656566.2010.497720","volume":"11","author":"R Buynak","year":"2010","unstructured":"Buynak R, Shapiro DY, Okamoto A, Van Hove I, Rauschkolb C, Steup A, et al. Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled phase III study. Expert Opin Pharmacother. 2010;11:1787\u2013804.","journal-title":"Expert Opin Pharmacother"},{"key":"268_CR56","unstructured":"National Prescribing Service. Tapentadol sustained release (Palexia SR) for chronic, severe disabling pain; Canberra; 2014. http:\/\/www.nps.org.au\/publications\/health-professional\/nps-radar\/2014\/june-2014\/tapentadol . Accessed 22 Feb 2015."},{"key":"268_CR57","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s12325-010-0036-3","volume":"27","author":"B Lange","year":"2010","unstructured":"Lange B, Kuperwasser B, Okamoto A, Steup A, Haufel T, Ashworth J, et al. Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain. Adv Ther. 2010;27:381\u201399.","journal-title":"Adv Ther"},{"key":"268_CR58","unstructured":"Therapeutic Goods Administration. Australian public assessment report for tapentadol Palexia SR. Department of Health Australian Government, editor. Canberra: 2011. http:\/\/www.tga.gov.au\/file\/1393\/download . Accessed 22 Feb 2015."},{"key":"268_CR59","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1185\/03007995.2011.611494","volume":"27","author":"R Riemsma","year":"2011","unstructured":"Riemsma R, Forbes C, Harker J, Worthy G, Misso K, Schafer M, et al. Systematic review of tapentadol in chronic severe pain. Curr Med Res Opin. 2011;27:1907\u201330.","journal-title":"Curr Med Res Opin"},{"key":"268_CR60","unstructured":"Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. http:\/\/www.cochrane-handbook.org . Accessed 22 Feb 2015."},{"key":"268_CR61","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1185\/03007995.2012.739151","volume":"28","author":"S Mercadante","year":"2012","unstructured":"Mercadante S, Porzio G, Ferrera P, Aielli F, Adile C, Ficorella C, et al. Tapentadol in cancer pain management: a prospective open-label study. Curr Med Res Opin. 2012;28:1775\u20139.","journal-title":"Curr Med Res Opin"},{"key":"268_CR62","first-page":"1","volume":"8","author":"A Schikowski","year":"2015","unstructured":"Schikowski A, Krings D, Schwenke K. Tapentadol prolonged release for severe chronic cancer-related pain: effectiveness, tolerability, and influence on quality of life of the patients. J Pain Res. 2015;8:1\u20138.","journal-title":"J Pain Res"},{"key":"268_CR63","doi-asserted-by":"crossref","first-page":"329","DOI":"10.36076\/ppj.2014\/17\/329","volume":"17","author":"HG Kress","year":"2014","unstructured":"Kress HG, Koch ED, Kosturski H, Steup A, Karcher K, Lange B, et al. Tapentadol prolonged release for managing moderate to severe, chronic malignant tumor-related pain. Pain Physician. 2014;17:329\u201343.","journal-title":"Pain Physician"},{"key":"268_CR64","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1586\/17512433.2014.889562","volume":"7","author":"B Desai","year":"2014","unstructured":"Desai B, Freeman E, Huang E, Hung A, Knapp E, Breunig IM, et al. Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy. Exp Rev Clin Pharmacol. 2014;7:203\u20139.","journal-title":"Exp Rev Clin Pharmacol"},{"key":"268_CR65","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.clinthera.2012.02.011","volume":"34","author":"M Obradovic","year":"2012","unstructured":"Obradovic M, Ikenberg R, Hertel N, Antonanzas F, Galvez R, Liedgens H. Cost-effectiveness of tapentadol in severe chronic pain in Spain: a cost analysis of data from RCTs. Clin Ther. 2012;34:926\u201343.","journal-title":"Clin Ther"},{"key":"268_CR66","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1185\/03007995.2014.894501","volume":"30","author":"F Coluzzi","year":"2014","unstructured":"Coluzzi F, Ruggeri M. Clinical and economic evaluation of tapentadol extended release and oxycodone\/naloxone extended release in comparison with controlled release oxycodone in musculoskeletal pain. Curr Med Res Opin. 2014;30:1139\u201351.","journal-title":"Curr Med Res Opin"},{"key":"268_CR67","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3111\/13696998.2012.670174","volume":"15","author":"R Ikenberg","year":"2012","unstructured":"Ikenberg R, Hertel N, Moore RA, Obradovic M, Baxter G, Conway P, et al. Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine. J Med Econ. 2012;15:724\u201336.","journal-title":"J Med Econ"},{"key":"268_CR68","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1185\/03007995.2014.957823","volume":"31","author":"C Scarpignato","year":"2015","unstructured":"Scarpignato C, Gatta L. Comparing tapentadol to oxycodone\/naloxone combination: building castles in the air. Curr Med Res Opin. 2015;31:335\u20138.","journal-title":"Curr Med Res Opin"},{"key":"268_CR69","unstructured":"National Health Service. NHS Electronic Drug Tarriff. 2015. http:\/\/www.ppa.org.uk\/edt\/January_2015\/mindex.htm . Accessed 21 Jan 2015."},{"key":"268_CR70","doi-asserted-by":"crossref","first-page":"833","DOI":"10.4140\/TCP.n.2009.833","volume":"24","author":"DR Guay","year":"2009","unstructured":"Guay DR. Is tapentadol an advance on tramadol? Consult Pharm. 2009;24:833\u201340.","journal-title":"Consult Pharm"},{"key":"268_CR71","unstructured":"Anonymous. Tapentadol. Acute or chronic pain: no therapeutic advance. Prescrire Int. 2014;23:121\u20134."},{"key":"268_CR72","doi-asserted-by":"crossref","unstructured":"Anonymous. Tapentadol (Palexia) for moderate to severe acute pain. Drug Ther Bull. 2012;50:30\u20133.","DOI":"10.1136\/dtb.2012.02.0092"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-015-0268-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-015-0268-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-015-0268-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:55:52Z","timestamp":1652144152000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-015-0268-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,30]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["268"],"URL":"https:\/\/doi.org\/10.1007\/s40266-015-0268-7","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,30]]}}}